GlaxoSmithKline, King of Prussia, PA
Christopher A. Evans is a Section Manager of the Bioanalytical Sciences and Development group of the Worldwide Bioanalysis and Systems Management within PCD-DMPK at GlaxoSmithKline Pharmaceuticals R&D, based in King of Prussia, PA. In this current role he co-leads the world-wide effort responsible for the investigation, evaluation, and implementation of novel technologies and processes to enhance the way that the quantitative bioanalysis of drugs is performed. One of the primary goals of this group is to continue the investigation into Dried Blood Spot (DBS) technology and fundamentals.
He obtained a B.S. in Chemistry from the University of Maryland at College Park and his Ph.D. in Analytical Chemistry from Purdue University. Prior to his current role over the last two years, Christopher led a discovery-DMPK group for nearly seven years, also within GlaxoSmithKline.